Taurine

Taurine

SCHEMBL30179154

N[13CH2][13CH2]S(=O)(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Taurine SCHEMBL30191395 1.00 — —
Taurine SCHEMBL42632 1.00 BLM (1.00) —
Taurine SCHEMBL23068 1.00 — —
Taurine SCHEMBL2422017 0.97 — —
Taurine SCHEMBL8052521 0.97 BLM (0.93) —
Taurine SCHEMBL15194490 0.97 — —
Taurine SCHEMBL10626136 0.97 — —
Taurine SCHEMBL688316 0.97 — —
Taurine SCHEMBL11449240 0.97 — —
Taurine SCHEMBL1100954 0.97 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4133266-A1 IMPROVED METHODS FOR EVALUATING LIVER FUNCTION Hepquant, LLC (US) 2023-02-15 — — EP claimed
CN-119028455-B Use of metabolites in prediction of immune reconstitution outcome after antiretroviral therapy of HIV-infected persons 中国人民解放军总医院第五医学中心 2025-05-16 — — CN disclosed
CN-119028455-A Use of metabolites in prediction of immune reconstitution outcome after antiretroviral therapy of HIV-infected persons 中国人民解放军总医院第五医学中心 2024-11-26 — — CN disclosed
EP-4133266-A1 IMPROVED METHODS FOR EVALUATING LIVER FUNCTION Hepquant, LLC (US) 2023-02-15 — — EP disclosed
Send feedback